Status:
WITHDRAWN
Evaluation of the Thyroid Volume After Radiofrequency Ablation of Thyroid Nodules and Recurrent Thyroid
Lead Sponsor:
Olympus Surgical Technologies Europe
Conditions:
Thyroid Nodule
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Thyroid nodules are among the common alterations of the thyroid. Depending on the detection method the prevalence is between 20% and 50%, whereas the incidence increases with improvement of ultrasonic...
Eligibility Criteria
Inclusion
- The patient must have given written (personally signed and dated) informed consent before completing any study-related procedures (i.e. any assessment or evaluation that would not have formed part of their normal medical care).
- The patient must be aged 18yrs or older.
- The patient must be able to understand, and be willing to comply with the requirements of the protocol
- The patient is not pregnant
- The patient has the diagnosis of benign thyroid nodules, struma diffusa, struma uninodosa, struma multinodosa, struma per magna, Thyroidea nodosa or Thyroidea multinodosa
- The patient rejected surgery The patient rejected sole radioiodine therapy
Exclusion
- Malign nodules
- Pregnancy
- Pacemaker near the target issue (\<4cm)
- Nerve stimulating device
- High fever
- Prosthesis for the inner ear
Key Trial Info
Start Date :
November 10 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 30 2022
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03395925
Start Date
November 10 2017
End Date
January 30 2022
Last Update
December 23 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Johann-Wolfgang Goethe University
Frankfurt, Germany, 60590